NEU 2.28% $13.30 neuren pharmaceuticals limited

With the expected build up to the top line results for Phase 2...

  1. 326 Posts.
    lightbulb Created with Sketch. 57
    With the expected build up to the top line results for Phase 2 Trofinetide in Fragile X syndrome around the corner...at these prices it would have to be one of the best spec buys on the market. I'm a very happy buyer and owner of this stock and will continue to accumulate at these prices...

    DYOR not financial advice just opinion...
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.